Fractyl Health (GUTS) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkyAI (SKYA) has outperformed Fractyl Health (GUTS) over the past year, losing 23.0% versus a loss of 95.1%. Fractyl Health is the larger company by market cap ($10.9 million vs $7.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GUTS | SKYA |
|---|---|---|
| Share price | $0.82 | $2.18 |
| Market cap | $10.88M | $7.82M |
| 1-day change | -14.16% | -45.50% |
| YTD return | -96.89% | +7.39% |
| 1-year return | -95.12% | -22.97% |
| P/E ratio (TTM) | — | 2.83 |
| EPS (TTM) | $-3.14 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $0 | $204.12K |
| Revenue growth (YoY) | -100.00% | — |
| Net income (latest FY) | $-140.95M | $-282.50M |
| Gross margin | — | -202.49% |
| Operating margin | — | -132145.49% |
| Net margin | — | -138400.02% |
| 52-week high | $29.34 | $4.39 |
| 52-week low | $0.784 | $0.91 |
| Distance from 52-week high | -97.21% | -50.34% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +7265.85% | — |
| Average volume | 504.39K | 1.74M |
| Shares outstanding | 13.26M | 3.59M |
| Employees | 100 | 30 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKYA has outperformed GUTS by 72.2 percentage points over the past year.
About Fractyl Health
GUTS stock →Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Health Care · Medical/Dental Instruments · 100 employees
About SkyAI
SKYA stock →SkyAI, Inc., a financial technology company with a Solana digital asset treasury that is building an agentic finance platform. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa.
Health Care · Medical/Dental Instruments · 30 employees
GUTS vs SKYA FAQ
Which is bigger, Fractyl Health or SkyAI?
Fractyl Health (GUTS) is larger, with a market capitalization of $10.88M compared with $7.82M for SkyAI (SKYA).
Which stock has performed better over the past year, GUTS or SKYA?
SKYA returned -22.97% over the past 12 months, compared with -95.12% for GUTS (price return, excluding dividends). Past performance does not predict future results.
Are Fractyl Health and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.